Kiromic Biopharma Inc
OTC:KRBP
Cash Flow Statement
Cash Flow Statement
Kiromic Biopharma Inc
| Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||
| Net Income |
(28)
|
(19)
|
(26)
|
(29)
|
(33)
|
(38)
|
(35)
|
(33)
|
(31)
|
(23)
|
(21)
|
(22)
|
(22)
|
(25)
|
(27)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Stock-Based Compensation |
5
|
6
|
4
|
3
|
2
|
1
|
1
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
1
|
|
| Other Non-Cash Items |
15
|
5
|
4
|
3
|
2
|
2
|
5
|
5
|
5
|
5
|
1
|
1
|
0
|
1
|
1
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(0)
|
(1)
|
1
|
(0)
|
2
|
6
|
4
|
5
|
3
|
(3)
|
(3)
|
(4)
|
(5)
|
1
|
4
|
|
| Cash from Operating Activities |
(12)
N/A
|
(14)
-10%
|
(20)
-48%
|
(25)
-24%
|
(28)
-9%
|
(29)
-5%
|
(24)
+18%
|
(20)
+15%
|
(21)
-2%
|
(20)
+4%
|
(21)
-7%
|
(23)
-7%
|
(25)
-8%
|
(21)
+13%
|
(19)
+8%
|
|
| Investing Cash Flow | ||||||||||||||||
| Capital Expenditures |
(2)
|
(1)
|
(2)
|
(4)
|
(6)
|
(6)
|
(5)
|
(2)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(2)
N/A
|
(1)
+43%
|
(2)
-56%
|
(4)
-135%
|
(6)
-45%
|
(6)
+4%
|
(5)
+18%
|
(2)
+51%
|
0
N/A
|
(0)
N/A
|
(0)
-40%
|
(0)
-10%
|
(0)
-43%
|
(0)
-37%
|
(0)
+18%
|
|
| Financing Cash Flow | ||||||||||||||||
| Net Issuance of Common Stock |
18
|
55
|
40
|
0
|
40
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
4
|
10
|
17
|
24
|
23
|
24
|
26
|
20
|
18
|
|
| Other |
0
|
(6)
|
(3)
|
0
|
0
|
0
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
|
| Cash from Financing Activities |
16
N/A
|
50
+217%
|
37
-25%
|
37
0%
|
37
0%
|
0
-100%
|
4
+38 900%
|
10
+146%
|
17
+76%
|
24
+42%
|
24
0%
|
25
+3%
|
26
+7%
|
20
-23%
|
18
-9%
|
|
| Change in Cash | ||||||||||||||||
| Net Change in Cash |
1
N/A
|
35
+2 943%
|
15
-56%
|
8
-49%
|
3
-56%
|
(35)
N/A
|
(25)
+29%
|
(13)
+47%
|
(4)
+71%
|
4
N/A
|
3
-35%
|
2
-37%
|
1
-9%
|
(1)
N/A
|
(1)
-6%
|
|
| Free Cash Flow | ||||||||||||||||
| Free Cash Flow |
(15)
N/A
|
(15)
-3%
|
(22)
-48%
|
(30)
-33%
|
(34)
-14%
|
(35)
-3%
|
(29)
+18%
|
(23)
+21%
|
(21)
+9%
|
(20)
+3%
|
(21)
-7%
|
(23)
-7%
|
(25)
-8%
|
(22)
+13%
|
(20)
+8%
|
|